down arrow

Aurobindo Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,095.40
37.45 (3.54%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.81 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,086.401,110.00

52 Week

994.351,592.55
Valuation
Technical
Day's Volume

CASH

8.81 lacs (-73.47%) Volume

Shareholding (Dec 2024)

FII

16.29%

Held by 648 FIIs

DII

25.21%

Held by 64 DIIs

Promoter

51.82%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 6.08% of over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 64,184 Cr (Large Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

11.89%

stock-summary
Price to Book

2.01

Revenue and Profits (1 Year):
Net Sales:
7,979 Cr
(Quarterly Results - Dec 2024)
Net Profit:
846 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-26.68%
0%
-26.68%
1 Year
-1.2%
0%
-1.2%
2 Years
101.81%
0.73%
102.54%
3 Years
57.06%
2.10%
59.16%
4 Years
16.08%
1.65%
17.73%
5 Years
138.1%
2.81%
140.91%

Latest dividend: 1.5 per share ex-dividend date: Feb-20-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.99%
EBIT Growth (5y)
6.08%
EBIT to Interest (avg)
32.60
Debt to EBITDA (avg)
1.14
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.86
Tax Ratio
29.69%
Dividend Payout Ratio
8.31%
Pledged Shares
17.83%
Institutional Holding
41.50%
ROCE (avg)
15.20%
ROE (avg)
11.95%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
33
Price to Book Value
2.01
EV to EBIT
13.03
EV to EBITDA
9.87
EV to Capital Employed
1.96
EV to Sales
2.06
PEG Ratio
0.64
Dividend Yield
NA
ROCE (Latest)
15.09%
ROE (Latest)
11.89%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

17.8303

Mutual Funds

Held by 33 Schemes (17.81%)

FIIs

Held by 648 FIIs (16.29%)

Promoter with highest holding

Rpr Sons Advisors Private Limited, Mrs.p.suneela Rani (jointly Holding) (33.5%)

Highest Public shareholder

Hdfc Mutual Fund-hdfc Arbitrage Fund (4.33%)

Individual Investors Holdings

5.52%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.34% vs 3.03% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 3.48% vs -11.08% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,978.52",
          "val2": "7,796.07",
          "chgp": "2.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,577.98",
          "val2": "1,566.14",
          "chgp": "0.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "118.48",
          "val2": "112.70",
          "chgp": "5.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "845.81",
          "val2": "817.38",
          "chgp": "3.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.99%",
          "val2": "20.48%",
          "chgp": "-0.49%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 9.19% vs 17.49% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 30.77% vs 42.79% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15,363.09",
          "val2": "14,069.94",
          "chgp": "9.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,185.71",
          "val2": "2,554.60",
          "chgp": "24.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "223.74",
          "val2": "124.73",
          "chgp": "79.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-69.75",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,736.60",
          "val2": "1,327.93",
          "chgp": "30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.09%",
          "val2": "18.32%",
          "chgp": "2.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.96% vs 16.53% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 14.05% vs 59.31% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23,341.61",
          "val2": "21,421.72",
          "chgp": "8.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,763.69",
          "val2": "4,155.91",
          "chgp": "14.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "342.22",
          "val2": "200.28",
          "chgp": "70.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-69.75",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,582.41",
          "val2": "2,264.22",
          "chgp": "14.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.41%",
          "val2": "19.40%",
          "chgp": "1.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 16.68% vs 5.97% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 64.62% vs -27.21% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29,001.87",
          "val2": "24,855.38",
          "chgp": "16.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,843.00",
          "val2": "3,718.64",
          "chgp": "57.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "289.71",
          "val2": "140.48",
          "chgp": "106.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-191.86",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,172.97",
          "val2": "1,927.50",
          "chgp": "64.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.36%",
          "val2": "15.11%",
          "chgp": "5.25%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
7,978.52
7,796.07
2.34%
Operating Profit (PBDIT) excl Other Income
1,577.98
1,566.14
0.76%
Interest
118.48
112.70
5.13%
Exceptional Items
0.00
0.00
Consolidate Net Profit
845.81
817.38
3.48%
Operating Profit Margin (Excl OI)
19.99%
20.48%
-0.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.34% vs 3.03% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 3.48% vs -11.08% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
15,363.09
14,069.94
9.19%
Operating Profit (PBDIT) excl Other Income
3,185.71
2,554.60
24.70%
Interest
223.74
124.73
79.38%
Exceptional Items
0.00
-69.75
100.00%
Consolidate Net Profit
1,736.60
1,327.93
30.77%
Operating Profit Margin (Excl OI)
21.09%
18.32%
2.77%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 9.19% vs 17.49% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 30.77% vs 42.79% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
23,341.61
21,421.72
8.96%
Operating Profit (PBDIT) excl Other Income
4,763.69
4,155.91
14.62%
Interest
342.22
200.28
70.87%
Exceptional Items
0.00
-69.75
100.00%
Consolidate Net Profit
2,582.41
2,264.22
14.05%
Operating Profit Margin (Excl OI)
20.41%
19.40%
1.01%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.96% vs 16.53% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 14.05% vs 59.31% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
29,001.87
24,855.38
16.68%
Operating Profit (PBDIT) excl Other Income
5,843.00
3,718.64
57.13%
Interest
289.71
140.48
106.23%
Exceptional Items
-191.86
0.00
Consolidate Net Profit
3,172.97
1,927.50
64.62%
Operating Profit Margin (Excl OI)
20.36%
15.11%
5.25%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 16.68% vs 5.97% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 64.62% vs -27.21% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Aurobindo Pharma Ltd. stock-summary
stock-summary
Aurobindo Pharma Ltd.
Large Cap
Pharmaceuticals & Drugs
Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
Company Coordinates stock-summary
Company Details
Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet Hyderabad Telangana : 500038
stock-summary
Tel: 91-40-23736370
stock-summary
http://www.aurobindo.com
stock-summary
info@aurobindo.com/investorgrievanc
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."